ArticleAnnals of medicine and surgery (2012)2026
Very late extragonadal recurrence of testicular seminoma presenting as a bladder mass: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Very late relapse of testicular seminoma is rare and typically occurs at conventional metastatic sites such as the retroperitoneum, mediastinum, or lungs. Extragonadal recurrence involving the urinary bladder is particularly uncommon and may pose diagnostic challenges. We report the case of a 52-year-old male who presented with painless visible hematuria 16 years after undergoing radical inguinal orchidectomy for stage I testicular seminoma. Imaging revealed a large infiltrative mass arising from the left posterolateral wall of the urinary bladder, with extension into the prostate and distal ureter, resulting in severe hydronephrosis. Serum tumor markers, including alpha-fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase, remained within normal limits. Transurethral resection of the bladder tumor was performed, and histopathological examination, supported by immunohistochemistry, demonstrated features consistent with classical seminoma. The disease was characterized as locally advanced, with regional lymph node involvement and no evidence of distant metastases. Multidisciplinary management was initiated, including systemic platinum-based chemotherapy and urinary decompression. This case illustrates that seminoma may rarely recur after prolonged disease-free intervals and at atypical anatomical sites, with findings supporting late metastatic recurrence rather than a primary extragonadal germ cell tumor. It also emphasizes that normal tumor marker levels do not exclude recurrence and that histopathological confirmation remains essential for accurate diagnosis. Recognition of unusual presentations in long-term survivors of germ cell tumors is important to facilitate timely diagnosis and appropriate management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.